How much funding has Pharmion raised?

Pharmion has raised $105.0M in total funding, most recently a Series B round.

Who are Pharmion's investors?

Pharmion's investors include Celgene Corporation, NEA, Aberdare Ventures, Bay City Capital, Domain Associates, Greenspring.

Where is Pharmion headquartered?

Pharmion is headquartered in Boulder, Colorado, United States.

What industry is Pharmion in?

Pharmion operates in Biotech, Drug Development.

How many employees does Pharmion have?

Pharmion has 201-500 employees.

Pharmion

Closed

Boulder, United States · Founded 1999 · $105.0M raised

Biotech

Drug Development

Headquarters: Boulder, Colorado
Employees: 201–500
Founded: 1999
Business Model: B2B

Website: pharmion.com
Total Funding: $105.0M
Last Round: $40.0M Series BNov 2002
Rounds: 3

About

Pharmion Corporation was a specialty pharmaceutical company headquartered in Boulder, Colorado, focused on acquiring and commercializing innovative medicines for hematology and oncology, particularly for European and other international markets. Founded in 1999, Pharmion commercialized drugs including azacitidine (Vidaza) and thalidomide for hematologic malignancies, and was acquired by Celgene Corporation in 2008.

Summary

Pharmion is a Biotech company based in Boulder, United States, founded in 1999. It has raised $105.0M in total across 3 rounds, most recently a $40.0M Series B round in Nov 2002. Investors include Celgene Corporation, NEA and Aberdare Ventures.